|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$1.48 |
$1.54 |
$1.40 |
$1.40 |
378.60K | 04/22/2024 |
$1.40 |
$1.45 |
$1.37 |
$1.41 |
295.60K | 04/23/2024 |
$1.40 |
$1.48 |
$1.40 |
$1.44 |
123.90K | 04/24/2024 |
$1.42 |
$1.45 |
$1.41 |
$1.42 |
110.00K | 04/25/2024 |
$1.42 |
$1.46 |
$1.39 |
$1.43 |
175.50K |
|
Spero Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments involving bacterial infections. Co.'s product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial pulmonary disease. Co.'s partnership-directed programs consist of tebipenem pivoxil hydrobromide, which is designed to be oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections; and SPR206, which is an IV-administered antibiotic being developed as an option to treat multi-drug resistant Gram-negative bacterial infections in the hospital setting. | |
|
Spero Therapeutics (SPRO) has the following price history information. Looking back at SPRO historical stock prices for the last five trading days, on April 19, 2024, SPRO opened at $1.48, traded as high as $1.54 and as low as $1.40, and closed at $1.40. Trading volume was a total of 378.60K shares. On April 22, 2024, SPRO opened at $1.40, traded as high as $1.45 and as low as $1.37, and closed at $1.41. Trading volume was a total of 295.60K shares. On April 23, 2024, SPRO opened at $1.40, traded as high as $1.48 and as low as $1.40, and closed at $1.44. Trading volume was a total of 123.90K shares. On April 24, 2024, SPRO opened at $1.42, traded as high as $1.45 and as low as $1.41, and closed at $1.42. Trading volume was a total of 110.00K shares. On April 25, 2024, SPRO opened at $1.42, traded as high as $1.46 and as low as $1.39, and closed at $1.43. Trading volume was a total of 175.50K shares.
SPRO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Spero Therapeutics shares, starting with a $10,000 purchase of SPRO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/02/2017 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$11.50 |
|
End price/share: |
$1.43 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-87.57% |
|
Average Annual Total Return: |
-27.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,243.61 |
|
Years: |
6.48 |
|
|
|
Date |
Close |
04/19/2024 | $1.40 | 04/22/2024 | $1.41 | 04/23/2024 | $1.44 | 04/24/2024 | $1.42 | 04/25/2024 | $1.43 |
|
|